The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 752
Last updated 2019-10-23
Summary
Background: The mean arterial pressure( MAP) is a key pressure index to improve tissue perfusion. At present, there are no surprising results of large-scale clinical studies on sublingual microcirculation. The changes of sublingual microcirculation were more severe in septic shock non-survivors than survivors. Purpose: This study is mean to increase the MAP in septic shock patients whether with chronic hypertension or not, so as to observe the change of the microcirculation and prognosis. Method: This is a single-center, randomized, prospective cohort study. Eligible patients will be allocated into chronic hypertension or denying chronic hypertension group. These patients will be treat with vasopressors to maintain MAP at 90±5 mmHg and 70±5 mmHg. Outcome: The 28-day all-cause mortality, the 90-day all-cause mortality, the 28-day without organ dysfunction days, the Changes of sublingual microcirculation, SOFA, APACHE-Ⅱ score Will be recorded.
Conditions
- Septic Shock
Interventions
- OTHER
-
vasopressors
control the mean arterial pressure with vasopressors
Sponsors & Collaborators
-
Fujian Provincial Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2021-01-30
- Completion
- 2021-11-30
More Related Trials
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Early Goal Directed Sedation on Microcirculation in Septic Shock
NCT02612363 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
NCT02884011 ·Status: COMPLETED
-
Comparison of Vasopressin and Other Pressors in Septic Shock
NCT00269685 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
NCT06426407 ·Status: TERMINATED
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
NCT06122987 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock
NCT02069288 ·Status: WITHDRAWN ·Phase: PHASE3
-
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790 ·Status: COMPLETED ·Phase: PHASE4
-
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
NCT02306239 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock
NCT02453425 ·Status: COMPLETED ·Phase: NA
-
Early Use of Norepinephrine in Septic Shock Resuscitation
NCT01945983 ·Status: COMPLETED ·Phase: NA
-
Comparison of Radial and Femoral Artery Site Invasive Blood Pressure Measurement in Septic Shock Patients
NCT03475667 ·Status: COMPLETED
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients
NCT05080543 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
Shenfu Injection Improves Arterial Vascular Reactivity
NCT03749525 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain
NCT02706379 ·Status: UNKNOWN ·Phase: NA
-
Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
NCT05833607 ·Status: UNKNOWN
-
Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 ·Status: COMPLETED
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED